Table 3.
Adjusted Mortality Hazard Ratio [95% CI] | p value | |
---|---|---|
| ||
Implant 2009–10 | 1.24 [1.12–1.37] | <0.001 |
| ||
Age ≥70 | 1.40 [1.25–1.58] | <0.001 |
| ||
Female | 1.16 [1.05–1.30] | 0.005 |
| ||
DT | 1.32 [1.20–1.45] | <0.001 |
| ||
BMI, kg/m2 | 1.01 [1.00–1.01] | 0.058 |
| ||
Prior sternotomy | 1.37 [1.25–1.50] | <0.001 |
| ||
Vasopressor use | 1.19 [1.00–1.41] | 0.056 |
| ||
Inotrope use | 0.95 [0.83–1.09] | 0.47 |
| ||
Dialysis | 1.85 [1.42–2.41] | <0.001 |
| ||
Ventilator support | 1.17 [0.97–1.42] | 0.11 |
| ||
INTERMACS Profile | <0.001 | |
1 | 1.23 [1.02–1.48] | 0.027 |
2 | 1.24 [1.07–1.44] | 0.004 |
3 | 0.95 [0.81–1.11] | 0.53 |
4–7 (reference) | ---- | ---- |
| ||
Creatinine, per mg/dL | 1.14 [1.09–1.19] | <0.001 |
| ||
Albumin, per g/dL | 0.92 [0.87–0.98] | 0.008 |
| ||
INR | 1.05 [0.96–1.16] | 0.31 |
BMI= body mass index, CI= confidence interval, DT= destination therapy, INR= international normalized ratio